ClinicalTrials.Veeva

Menu

Laparoscopic Versus Open Surgical Repair of Genitovesical Fistula in Females

S

South Valley University

Status

Enrolling

Conditions

Genitovesical Fistula

Treatments

Procedure: Open surgical Interference

Study type

Interventional

Funder types

Other

Identifiers

NCT07043062
Female Genitovesical fistula

Details and patient eligibility

About

Fistula is an abnormal passway that connects two organs or vessels that do not connect normally.

Genitourinary fistula refers to a fistula that occurs between reproductive tract organs (vagina, cervix, and uterus), and lower urinary tract (bladder, urethra, and pelvic ureters).

It is a serious condition which can significantly influence the biological and psychological condition of women, with a negative impact on the quality of life.

Full description

Fistula is an abnormal passway that connects two organs or vessels that do not connect normally.

Genitourinary fistula refers to a fistula that occurs between reproductive tract organs (vagina, cervix, and uterus), and lower urinary tract (bladder, urethra, and pelvic ureters).

It is a serious condition which can significantly influence the biological and psychological condition of women, with a negative impact on the quality of life.

In developed countries, iatrogenic injury during hysterectomy or pelvic surgery is the primary cause of fistulae . However, the etiology differs in developing countries, being secondary to prolonged, obstructed, complicated labor.

Genitovesical fistulae are one of the most devastating complications in the urogynecology setting. The commonest type of these fistulae is the vesicovaginal fistula (VVF);the patients Suffering from continuous urinary leakage through the vagina and urinary smell, patients with VVF face hygienic, social, infectious, psychological, and sexual problems.

Vesicouterine fistulae (VUF) are not as common as VVF. In 1908, the first case was reported by Knipe , and later in 1957, Youssef reported on the classic symptoms of VUF. These symptoms included amenorrhea and cyclic hematuria, or menouria; known afterward as Youssef's syndrome. The prevalence of these fistulae is estimated to be 1-4% of all genitourinary fistulae.

Several options for the management of such fistulae have been discussed; these include conservative treatment with prolonged catheterization , open surgery, cysto-fulguration, endourology, and laparoscopy/robotic surgery. The decision-making is guided by the patient characteristics, etiology, and the experience of the treating surgeon.

Laparoscopy is of great advantage when compared to open surgery, including safe, effective, minimally invasive procedure, less postoperative pain, smaller incisions, lower blood loss, a shorter hospital stay, and faster recovery. It is associated with a lower incidence of postoperative complications, including infections and improper wound healing

Enrollment

50 estimated patients

Sex

Female

Ages

25 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Females with Vesicovaginal fistula or Vesicouterine fistula.
  • Timing of repair after 2-6 months of beginning of symptoms and signs of fistula.

Exclusion criteria

  • Malignant , Recurrant or Post Radiation Genitovesical fistula.
  • Females with congenital disease in Bladder ,Uterus or Vagina.
  • Females with Vaginal or Uterine prolapse.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Group of Laparoscopic Repair
Active Comparator group
Description:
About 25 female patients suffering from Vesicovaginal fistula or Vesicouterine fistula and will be subjected to Laparoscopic repair of the fistula
Treatment:
Procedure: Open surgical Interference
Group of Open Surgical Repair
Active Comparator group
Description:
About 25 female patients suffering from Vesicovaginal fistula or Vesicouterine fistula and will be subjected to surgical repair of the fistula.
Treatment:
Procedure: Open surgical Interference

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Mahmoud Hassan, Assist.prof; Hassan Elshazly Khodary Hassanein, MSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems